Table 1.
Characteristics of the included studies.
Fig 1.
Selection process of studies included in the review.
Fig 2.
Risk of in-hospital mortality in septic patients with and without antiplatelet therapy (StataCorp. (2017).
Stata version 15.0. StataCorp LP).
Fig 3.
Risk of mortality at timepoints other than in-hospital mortality in septic patients with and without antiplatelet therapy (StataCorp. (2017).
Stata version 15.0. StataCorp LP).
Table 2.
Findings of the subgroup analysis.
Fig 4.
Risk of complications in septic patients with and without antiplatelet therapy (StataCorp. (2017).
Stata version 15.0. StataCorp LP).
Fig 5.
Length of intensive care unit (ICU) stay (in days) and overall hospital stay (in days) in septic patients with and without antiplatelet therapy (StataCorp. (2017).
Stata version 15.0. StataCorp LP).
Table 3.
Certainty of pooled evidence using the GRADE approach.